Position in PRAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$43,872,888
+$8,932,672 QoQ
Shares Held
131,046
+20.8% QoQ
Ownership
0.469%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#41
of 308 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Derivatives in PRAX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$1,858,610
PutShares
44,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. PRAX ranks #40 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in PRAX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,872,888 | 131,046 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $34,940,216 | 108,446 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $26,290,807 | 89,200 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,131,036 | 96,812 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,858,610 | 44,200 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $3,638,754 | 86,534 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,704,150 | 45,000 | Put | Defined | 2025-05-13 | |
| 2025-03-31 | $7,305,463 | 192,909 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,255,748 | 120,267 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,700,306 | 29,550 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,107,496 | 26,777 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $488 | 8 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $60,133 | 2,699 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $8,763 | 7,620 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $15,973 | 19,745 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $24,406 | 10,255 | Shares | Sole | 2023-02-08 | |
| 2022-06-30 | $383,931 | 156,707 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $734,282 | 71,918 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,696,268 | 86,105 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,016 | 55 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $6,403,392 | 116,383 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||